Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2022-10-17
Original market date: See footnote 1
2019-08-29
Product name:
IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION
DIN:
02483394
Product Monograph/Veterinary Labelling:
Date:
2020-10-19
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
JUNO PHARMACEUTICALS CORP.
402
2233 Argentia Road
Mississauga
Ontario
Canada
L5N 2X7
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Inhalation
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
12:08.08 , 48:12.04.12 , 12:12.08.12
Anatomical Therapeutic Chemical (ATC): See footnote 4
R03AL02 SALBUTAMOL AND IPRATROPIUM BROMIDE
Active ingredient group (AIG) number:See footnote5
0232902001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE MONOHYDRATE) | 0.5 MG / 2.5 ML |
| SALBUTAMOL (SALBUTAMOL SULFATE) | 2.5 MG / 2.5 ML |